FDA Investigator Nicholas P Diorio

Nicholas P Diorio has conducted inspections on 72 sites in 2 countries as of 05 Jan 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
72
Last Inspection Date:
05 Jan 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China
FDA Investigators that have inspected at least one site in common with Nicholas P Diorio:
Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana E Morales, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Ronga, Antoinette L Chancey, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Barry Cherney, PhD, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carrie Ann Plucinski, CDR Ileana Barreto Pettit, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charisse K Green, Charles L Zhou, Chase S Baldwin, Cheryl A Grandinetti, Christina A Miller, Christina V Santos, Christopher D Leach, Clinton J Lott, Clotia Cabbey Mensah, Colleen E Burke, Dariusz Galezowski, David Perkins, Debra I Love, Debra Lboyd Seale, Dell S Moller, Denarvis C Mendenhall, Denise M Digiulio, Dr. S Nar Ali, PhD, Dr. Zhou Chen (nmi), MD PhD, Eboni S Funderburk, Elizabeth L Philpy, Emilie E Kahn, Enrico Joset Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Gabriel Bermudez Picart, George Pyramides, Gregory R Dill, Howard Sklamberg, Humera T Khan, Jacob G Lutz, James E Roberts, James P Duggan, James W Plucinski, Janae D Price, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Johnson, Jeremy W Rotton, Jesse A Vazquez, Jill J Tillman, Jocelyn C Turner, Joel D Hustedt, John M Seale, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Justin R Hays, Karen Emasley Joseph, Kathleen S Tormey, Kristen E Szenderski, Kshitij A Patkar, Kujtim Sadiku, Latoya A Griffith, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurimer Kuilan Torres, LCDR Michael H Tollon, Lee Terry Moore, Lequita M Mayhew, Leslie D Hintz, Liliya V Bubiy, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Logan M Ebeling, Lorelei S Jarrell, Maksim A Levenchuk, Marcia A Worley, Margaret Torres Vazquez, Marie B Buen Bigornia, Mark G Peterson, Mark I Kaspar, Matthew T Sanchez, Michael A Taylor, Michael D Robinson, Michael E Maselli, Michele L Glendenning, Michele Perry Williams, Micmarie Ramos Rodriguez, Mihaly S Ligmond, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas Z Lu, Nicole E Knowlton, Nicole J Clausen, Nicole S Williams, Norman K Starks, Norman L Brown, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paul L Bellamy, Paula A Trost, Paula P Demichael, Peng Zhou, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca K Olin, Rebecca Rodriguez, Regan T Harp, Regina T Brown, Rita K Kabaso, Robert J Ham, Rona Leblanc, PhD, Rosemary Wood Sexton, Roshni J Patel, Ross J Grigsby, Russ R Rivy, Russell K Riley, Ruth Smith, Samina S Khan, Sandra A Hughes, Sean P Ryan, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Shelby N Turner, Simone E Pitts, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Eich, Sullan, Susan D Yuscius, Susan P Bruederle, Syed N Ali, Tamara Brey, Tara C Alcazar, Tenzin Jangchup, That Q Dang, Thomas J Arista, Todd M Stankewicz, Torrey M Ward, Tyler M Peterson, Tyler Peterson, Vaishali J Patel, Veronica Fuentes, MS, Vioela J Caze, William D Sherman, William R Weissinger, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvonne E Lozano

Nicholas P Diorio's Documents

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more